Inventiva (France)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 12 papers

  • Research Article
  • Citations3

The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature.

  • Feb 01, 2025
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  • Anneleen Heldens +15
  • Research Article
  • Citations43

MASLD/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists

  • May 01, 2024
  • Diabetes Research and Clinical Practice
  • Michael P Cooreman +2
  • Open Access
  • PDF
  • Addendum

Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas

  • May 30, 2023
  • Nature Communications
  • Leticia Laura Niborski +23
  • Single Book
  • Citations7

LA INVESTIGACIÓN CIENTÍFICA EN DIVERSAS CIENCIAS

  • Jan 01, 2022
  • Zenodo (CERN European Organization for Nuclear Research)
  • Marco Alberto Mendoza Pérez +71
  • Research Article
  • Citations11

Oral treatment for mucopolysaccharidosis VI: Outcomes of the first phase IIa study with odiparcil.

  • Dec 30, 2021
  • Journal of Inherited Metabolic Disease
  • Nathalie Guffon +12
  • Open Access
  • Research Article
  • Citations11

MPS VI associated ocular phenotypes in an MPS VI murine model and the therapeutic effects of odiparcil treatment

  • Jul 25, 2021
  • Molecular Genetics and Metabolism
  • Eugeni Entchev +12
  • Research Article
  • Citations286

Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆

  • Apr 29, 2020
  • Journal of Hepatology
  • Sander Lefere +14
  • Open Access
  • Research Article
  • Citations14

Inhibition of Interleukin-23-Mediated Inflammation with a Novel Small Molecule Inverse Agonist of RORγt.

  • Aug 02, 2019
  • The Journal of pharmacology and experimental therapeutics
  • Stephen B Gauld +23
  • Research Article

020 Evidence for altered peroxisome proliferator activated receptor (PPAR) pathway activity in a transgenic mouse model of scleroderma (TbRIIDk-fib): analysis of mouse skin, lung and explanted cells

  • Apr 01, 2019
  • Rheumatology
  • Emma Derrett-Smith +7
  • Abstract

AB0206 Pan-Ppar Agonist IVA337 is Effective in Prevention and Treatment of Experimental Skin Fibrosis

  • Jun 01, 2015
  • Annals of the Rheumatic Diseases
  • N Ruzehaji +8
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.